Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2015

View Archived Issues

Novel sedative compares favorably with propofol in dogs

Janssen's gamma-secretase modulator effective in AD models

AAV-mediated gene delivery shows promising results in AD models

New results presented for lapatinib in the treatment of recurrent ependymoma

Daiichi Sankyo receives approval in Japan for methylene blue

China organizations disclose analgesic frog skin oligopeptide

Merck & Co. reports new HIV integrase inhibitors

Kaken discloses novel EP4 receptor antagonists

Astellas presents compounds for breast cancer

Helix BioMedix patents human C-X-C chemokine-derived peptides

Innovate Biopharmaceuticals to acquire RG-1068 assets

Vectura to apply its inhaled drug delivery technology to Janssen asthma and COPD candidates

Minerva Neurosciences' neuregulin-1 analogue shows activity in primate model of Parkinson's disease

FDA approves Gadavist as contrast agent for pediatric patients under age 2

Phase III trial of perampanel in refractory partial-onset seizures meets primary endpoint

Manufacturing and distribution approval for selective SGLT2 inhibitor for diabetes

CytRx reports interim results from phase II trial of aldoxorubicin in GBM

BrainStorm Cell Therapeutics reports final results from phase IIa ALS study of NurOwn

Alnylam files application for phase I trial of ALN-AS1

Cenicriviroc receives FDA Fast Track designation

FDA awards fast track designation to IMMU-132 for triple-negative breast cancer

Sirnaomics files Chinese IND application for STP-705 for hypertrophic scars

Taiho files Japanese NDA for Yondelis in soft tissue sarcoma

European orphan drug designation for Kite Pharma's KTE-C19 for DLBCL

FDA grants orphan drug status to selinexor for multiple myeloma

Celiprolol receives FDA orphan drug status for Ehlers-Danlos syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...